Zhongkang CMH data display，2015 The total size of the digestive Stake Sports Bettingsystem and metabolic disease medication (according to terminal retail price，The same below) is 210.30 billion yuan，No. 3 among all drug categories。TOP10 Enterprise、Each of foreign -funded enterprises，But the share of foreign -funded enterprises accounts for 16.3%，Obverse advantages。

 

  With the accelerated pace of urban life in my country，Modern people's irregular diet increases。The digestive Stake Sports Bettingsystem and metabolic disease have seriously threatened people's health。According to the 2013 National Tumor Registration Center survey data, it shows，At present, the incidence of cancer in my country is ranked in the top ten: lung cancer、Stomach cancer、colorectal cancer、Liver cancer、esophageal Stake Sports Bettingcancer、Breast cancer、pancreatic cancer、lymphatic cancer、Bladder cancer and thyroid cancer，The digestive tract tumors account for 43.3%of the incidence of all cancer。

 

  Table 1 China ’s main disease mortality rate and composition statistics in China in 2014

 

 

  Data Source: "China Health and Family Planning Statistics Year 2015"

 

  Market potential is expected: 2016 The scale of medication will reach 227.428 billion yuan

 

  Drugs for digestive systems and metabolic diseases include digestive ulcers for medication、Hepatobiliary medication、During the digestive system tumor medication、Diabetes Medicine、Vitamin lack of medication, etc.。In recent years，The incidence and mortality of the digestive Stake Sports Bettingsystem and metabolic diseases gradually increase，The demand for the drug market for this type of disease has also increased continuously。According to Zhongkang CMH monitoring data,，2015 Gastrointestinal and metabolic diseases The overall scale of 210.300 billion yuan，No. 3 among all drug categories，increased by 10.3%over 2014，occupied 15.3%of the market share。As slow diseases gradually become popular attention points，Its drug market will also gradually expand，The scale of the digestive system and metabolic disease medication in 2016 will reach 227.428 billion yuan，The growth rate is expected to be 8.1%，The proportion of market share is still ranked 3。

 

 

  Hospital channels account for 70 %

 

  From the two major channels of hospitals and retail markets，The hospital is the main channel for the digestive system and the drug market for metabolic diseases，The scale of 2015 was 157.083 billion yuan，Market share accounted for 74.7%; the scale of the retail market digestive Stake Sports Bettingsystem and metabolic disease medication in 2015 was 53.217 billion yuan，The proportion is 25.3%。From the change of market share，Retail channels are growing year by year，With the in -depth advancement of the reform of public hospitals and the gradual expansion of the market for slow diseases，Retail channels may usher in better development opportunities in the next few years。

 

 

  Chemical drug share accounted for more than 60 %，The development of Chinese patent medicines has declined slightly

 

  According to Zhongkang CMH monitoring data,，Drugs and metabolic diseases are mainly chemicals，2015 market share is 69.1%，It is estimated that the share of 2016 accounts for 69.0%; the proportion of Chinese medicines in 2015 is 20.1% ，Just 1/3 of chemical medicines，From the perspective of development，Chinese patent medicine has a slight decline。

 

 

  The top ten brands of the category chemistry reached 24 billion，Akaba sugar tablets topped the list

 

  According to Zhongkang CMH monitoring data,，The size of the top ten brands of the digestive Stake Sports Bettingsystem and metabolic disease in 2015 is 24.048 billion yuan，increased 11.6%; Among them, Bayer Pharmaceutical Akapo candy tablets ranked first with a market share of 3.4%。According to the trend of market share of various brands，It is expected that most My stake betting appof the growth trends in the Great Gastrointestinal and metabolic diseases in 2016 are not obvious，It is expected that the Akapo sugar tablets of Bayer Medicine will continue to keep the first name。

 

 

  Class category has a strong growth trend in the category

 

  According to Zhongkang CMH monitoring data,，The size of the top ten brands in the 2015 digestive Stake Sports Bettingsystem and metabolic diseases is 11.639 billion yuan，increased by 26.9%; East Ejiao ranked first with 8.2%market share。According to the trend of market share of various brands，It is expected that most My stake betting appof the growth trends in the patent medicine in the TOP10 of the digestive system and metabolic disease in 2016 are strong。

 

 

  Novo and Nond Zhanzhan Biological Products 6 seats

 

  According to Zhongkang CMH monitoring data,，The size of the top ten brands of biological products for the 2015 digestive Stake Sports Bettingsystem and metabolic diseases was 14.986 billion yuan，increase 4.6%，and TOP10 biological products are all insulin products，Market share accounted for more than 60%，Diabetes for metabolic diseases can be used as biological products; biological products TOP10 brand，Foreign -funded brands，Among them, Nuo and Nord have occupied 6 seats; only two brands are shortlisted by domestic brands，It can be seen that domestic brands still need to be contributed in the field of digestive systems and metabolic diseases。

 

 

  In the top ten companies、Each of foreign -funded enterprises，Growth increase of 10.7%

 

  According to Zhongkang CMH monitoring data,，The size of the top ten companies in the digestive Stake Sports Bettingsystem and metabolic disease in 2015 was 58.853 billion yuan，increase 10.7%;、Foreign -funded enterprises each have 5 companies，The share of domestic -funded enterprises accounted for 11.7%，Foreign -funded enterprises share a total of 16.3%，Foreign -funded enterprises are more advantageous; of which Nuo and Nord are ranked first with a market share of 6.1%，Followed by China Resources Medicine，Market share is 3.5%。According to the trend of market share changes in various companies，It is expected that most of the domestic enterprise shares of the digestive system and metabolic diseases in 2016 will have a slight upward trend。

 

 

  Remarks: Dong'er Ejiao Co., Ltd. belongs to China Resources Medicine。